Nasus Pharma Ltd revenue

Nasus Pharma Ltd's revenue was $1.24bn in fiscal 2025.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Nasus Pharma Ltd: revenue history, annual
Fiscal year	2025Dec 2025
Revenue	1,235

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Revenue against peers

Pharmaceuticals: the closest covered companies by revenue. Last twelve months.

Company	Revenue	Growth	3-year growth a year
Nasus Pharma Ltd	$1.24bn	—	—
Trulieve Cannabis Corp.	$1.14bn	-3.9%	-0.6%
Indivior Pharmaceuticals, Inc.	$1.37bn	16.3%	—
Prestige Consumer Healthcare Inc.	$1.10bn	-1.4%	-0.7%
Phibro Animal Health Corp	$1.52bn	17.1%	15.8%
Lantheus Holdings, Inc.	$1.56bn	2.3%	11.4%

Compare with peers

Head to head: NSRX vs TRLV INDV vs NSRX NSRX vs PBH

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Nasus Pharma Ltd's SEC filings (10-K and 10-Q). How we read and check them: methodology and data sources. Not investment advice. Back to Nasus Pharma Ltd.